Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Dividends Calendar
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team

Nosa Plugs

0,88

 

SEK

 

+1,97 %

Mindre end 1K følgere

NOSA

First North Stockholm

Medical Equipment & Services

Health Care

Overview
Ownership
Investor consensus
Sammenligne
+1,97%
+15,18%
+13,99%
-7,37%
-5,38%
+30,37%
+106,57%
-90,72%
-95,11%

Nosa Plugs operates in the medical technology sector. The company is a developer of intranasal breathing products. The product range is broad and includes, for example, odor protection, nasal filters against airborne allergens and nasal protection used to reduce viruses and bacteria. The products are used, for example, by people who suffer from various allergies. The largest operations are found in the Nordic market, with the headquarters located in Stockholm.

Læs mere
Markedsværdi
228,46 mio. SEK
Aktieomsætning
534,64 t SEK
Omsætning
16,1 mio.
EBIT %
-64,1 %
P/E
-
Udbytteafkast, %
-
Finanskalender
22.8
2025

Delårsrapport Q2'25

7.11
2025

Delårsrapport Q3'25

13.2
2026

Årsrapport '25

Alle
Selskabsmeddelelser
Eksterne analyser
ViserAlle indholdstyper
Pressemeddelelse11.7.2025, 13.42

Carlsquare: Mrkt BUZZ, Nosa Plugs: Positive results and proof of concept

Nosa Plugs
Pressemeddelelse16.6.2025, 17.00

Carlsquare: Mrkt BUZZ, Nosa Plugs: First possible acquisition announced

Nosa Plugs
Pressemeddelelse21.5.2025, 13.20

Carlsquare: Equity research Nosa Plugs Q1, 2025: NOSA starting 2025 with consistent growth

Nosa Plugs

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Eksterne analyser15.5.2025, 08.50

Analyst Group Comment on Nosa Plugs Q1 Report

Nosa Plugs AB (“Nosa Plugs” or the “Company”) published the Company’s interim report for the first quarter of 2025 on May 15, 2025, which demonstrated continued strong operational development with high growth and improved profitability.

Nosa Plugs
Eksterne analyser2.4.2025, 09.25

Analyst Group Comments on Nosa Plugs Achieving Positive Cash Flow in Q1 2025

Nosa Plugs AB (“Nosa Plugs” or “the Company”) announced on April 2, 2025, that it has reached its target of achieving positive cash flow during the first quarter of 2025. This has been accomplished through strong growth in recent years and continued ...

Nosa Plugs
Pressemeddelelse2.4.2025, 08.03

Carlsquare: Mrkt BUZZ, Nosa Plugs: Cash flow in the black, goal achieved

Nosa Plugs
Eksterne analyser25.3.2025, 07.52

Analyst Group Comments on Nosa Plugs’ Launch of NOSA Nozoil in Germany

Nosa Plugs AB (“Nosa Plugs” or “the Company”) announced on March 24, 2025, that the Company is launching NOSA Nozoil Original and NOSA Nozoil Menthol, a moisturizing nasal spray designed for individuals with dry nasal mucosa, on the German pharmacy market...

Nosa Plugs
Eksterne analyser20.2.2025, 09.09

Nosa Plugs: The Expansion Continues - Analyst Group

Nosa Plugs AB ("Nosa Plugs" or the "Company") is a medical technology company that has developed intranasal breathing products for applications such as odor protection and olfactory training, achieving strong historical growth with a 36% CAGR between...

Nosa Plugs
Pressemeddelelse20.2.2025, 08.30

Carlsquare: Equity Research Update NOSA Q4 2024: Strong growth and announced M&A strategy

Nosa Plugs
Eksterne analyser14.2.2025, 11.32

Analyst Group Comment on Nosa Plugs Q4-report

On February 14, 2025, Nosa Plugs published the company’s interim report for the fourth quarter of 2024.

Nosa Plugs
Pressemeddelelse14.2.2025, 07.50

Carlsquare: First impression Nosa Plugs Q4, 2024: ending the year with strong growth

Nosa Plugs
Pressemeddelelse19.12.2024, 11.20

Carlsquare: Mrkt BUZZ Nosa Plugs: Drug Delivery patent submitted

Nosa Plugs
Pressemeddelelse19.11.2024, 09.13

Carlsquare: Equity research Nosa Plugs Q3, 2024: Strong growth with rise in valuation on the cards

Nosa Plugs
Pressemeddelelse8.11.2024, 08.22

Carlsquare: First impression Nosa Plugs Q3, 2024: Stronger sales than expected

Nosa Plugs
Pressemeddelelse29.8.2024, 12.40

Carlsquare: Equity research Nosa Plugs Q2, 2024: A second quarter with significant news flow

Nosa Plugs
Pressemeddelelse23.8.2024, 07.00

Carlsquare: First impression Nosa Plugs Q2, 2024: Record breaking sales and gross margin

Nosa Plugs
Pressemeddelelse20.6.2024, 13.40

Carlsquare: Mrkt BUZZ Nosa Plugs: New orders and distributor agreements

Nosa Plugs
Pressemeddelelse17.5.2024, 11.05

Carlsquare: Equity Research Update NOSA Q1, 2024: Tepid Q1 and updated company strategy

Nosa Plugs
Pressemeddelelse21.2.2024, 08.10

Carlsquare: Equity Research Update NOSA Q4, 2023: Record-breaking sales funding the pipeline

Nosa Plugs
Pressemeddelelse16.2.2024, 08.10

Carlsquare: First impression Nosa Plugs Q4, 2023: Smell training launched and Drug delivery in development

Nosa Plugs
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.